Spots Global Cancer Trial Database for oophorectomy
Every month we try and update this database with for oophorectomy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer | NCT00293540 | Breast Cancer | oophorectomy Tamoxifen | 18 Years - | International Breast Cancer Research Foundation | |
| Examining the Long-Term Risks of Oophorectomy | NCT00655447 | Coronary Heart ... Stroke Breast Cancer Ovarian Cancer Cancer Hip Fracture Death | 30 Years - 55 Years | Parker, William H., M.D. | ||
| Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy | NCT00084370 | brca1 Mutation ... brca2 Mutation ... Ovarian Cancer | celecoxib oophorectomy | 19 Years - | University of Alabama at Birmingham | |
| Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy | NCT00165204 | Menopause Postmenopausal ... Breast Cancer | Tibolone | 18 Years - | Dana-Farber Cancer Institute | |
| Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy | NCT00084370 | brca1 Mutation ... brca2 Mutation ... Ovarian Cancer | celecoxib oophorectomy | 19 Years - | University of Alabama at Birmingham | |
| Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | NCT00002580 | Breast Cancer | cyclophosphamid... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... conventional su... laparoscopic su... oophorectomy radiation thera... | - 70 Years | National Cancer Institute (NCI) | |
| Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer | NCT00293540 | Breast Cancer | oophorectomy Tamoxifen | 18 Years - | International Breast Cancer Research Foundation | |
| Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | NCT00002580 | Breast Cancer | cyclophosphamid... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... conventional su... laparoscopic su... oophorectomy radiation thera... | - 70 Years | National Cancer Institute (NCI) | |
| Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy | NCT00084370 | brca1 Mutation ... brca2 Mutation ... Ovarian Cancer | celecoxib oophorectomy | 19 Years - | University of Alabama at Birmingham | |
| Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk | NCT00043472 | Breast Cancer Ovarian Cancer | 19 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer | NCT00293540 | Breast Cancer | oophorectomy Tamoxifen | 18 Years - | International Breast Cancer Research Foundation | |
| Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | NCT00002582 | Breast Cancer | CMF regimen cyclophosphamid... doxorubicin hyd... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... oophorectomy radiation thera... | - | National Cancer Institute (NCI) | |
| Premenopausal Endocrine Responsive Chemotherapy Trial | NCT00066807 | Breast Cancer | chemotherapy exemestane tamoxifen triptorelin oophorectomy ovarian irradia... | 18 Years - 65 Years | ETOP IBCSG Partners Foundation | |
| Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations | NCT02760849 | Deleterious BAR... Deleterious BRC... Deleterious BRC... Deleterious BRI... Deleterious EPC... Deleterious MLH... Deleterious MSH... Deleterious MSH... Deleterious PAL... Deleterious PMS... Deleterious RAD... Deleterious RAD... Hereditary Brea... Premenopausal | Laboratory Biom... Oophorectomy Quality-of-Life... Salpingectomy Salpingo-Oophor... | 30 Years - 50 Years | M.D. Anderson Cancer Center | |
| Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations | NCT02760849 | Deleterious BAR... Deleterious BRC... Deleterious BRC... Deleterious BRI... Deleterious EPC... Deleterious MLH... Deleterious MSH... Deleterious MSH... Deleterious PAL... Deleterious PMS... Deleterious RAD... Deleterious RAD... Hereditary Brea... Premenopausal | Laboratory Biom... Oophorectomy Quality-of-Life... Salpingectomy Salpingo-Oophor... | 30 Years - 50 Years | M.D. Anderson Cancer Center | |
| Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy | NCT00165204 | Menopause Postmenopausal ... Breast Cancer | Tibolone | 18 Years - | Dana-Farber Cancer Institute | |
| Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer | NCT00002460 | Breast Cancer | goserelin aceta... tamoxifen citra... ablative endocr... oophorectomy | - 49 Years | National Cancer Institute (NCI) | |
| Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer | NCT00201851 | Breast Cancer | Tamoxifen Surgery: Oophor... | 18 Years - 50 Years | International Breast Cancer Research Foundation |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
